Is NRx Pharmaceuticals Inc (NRXPW) overvalued? · rev $242.0K
NRx Pharmaceuticals Inc (NRXPW) common stock listed on NASDAQ.
This page asks whether NRx Pharmaceuticals Inc (NRXPW) looks expensive on cached numbers — not a short thesis.
Latest reported NRXPW revenue for 2025-09-30 was $242.0K. Net income was -$5.9M. NRXPW currently screens at market cap $714.6M.
NRXPW currently screens at market cap $714.6M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next NRXPW 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the NRXPW stock page for the full model, not this heading.
Not investment advice.